Lista de obras -

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells

artículo científico publicado en 2017

CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals

artículo científico publicado en 2010

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox

artículo científico publicado en 2012

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

artículo científico publicado en 2006

Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.

artículo científico publicado en 2009

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

artículo científico publicado en 2009

Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression

artículo científico publicado en 2009

N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection

artículo científico publicado en 2011

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox

artículo científico publicado en 2009

Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.

artículo científico publicado en 2004

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

artículo científico publicado en 2008

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

artículo científico publicado en 2007

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

artículo científico publicado en 2006

Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells.

artículo científico publicado en 2011

Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization

artículo científico publicado en 2008

Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge

artículo científico publicado en 2007

Vaccinia virus replication is not affected by APOBEC3 family members

artículo científico publicado en 2006

Lista de obras de

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells

CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression

N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox

Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells.

Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization

Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge

Vaccinia virus replication is not affected by APOBEC3 family members